Slide 1Using genetic markers in clinical practice David Thomas Advisor: Merck Clinical trial: Gilead and Merck Slide 2 Using genetic markers in clinical practice IL28b test…

Slide 1Frequencies of Resistance-Associated Amino Acid Variants Following Combination Treatment with Boceprevir (BOC) Plus PEGINTRON (PegInterferon Alfa-2b) and Ribavirin…

Slide 1Non invasive fibrosis markers and/or liver biopsy Pierre Bedossa Department of Pathology, Hôpital Beaujon, Paris-Denis Diderot University FRANCE Slide 2 FIBROSIS…

Slide 1 5/14/2015 1 Interim Results from HCV SPRINT-1 Phase 2 Study of Boceprevir Plus Peginterferon alfa-2b/Ribavirin in Treatment-Naïve Subjects with Genotype-1 CHC T.…

Slide 1 Jenny HEATHCOTE Slide 2 Chronic Hepatitis C “The Non Responder”! Jenny Heathcote MD University of Toronto Slide 3 Mr R.H. Canadian First Nation’s Person 54…

Slide 1 Hepatitis web study H EPATITIS W EB S TUDY H EPATITIS C O NLINE Boceprevir (Victrelis) Prepared by: David Spach, MD & H. Nina Kim, MD Last Updated: March 6, 2014…

Peginterferon Alfa-2a plus Ribavirin vs Peginterferon Alfa-2b plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients J Berenguer*1, J González2,…

Frequencies of Resistance-Associated Amino Acid Variants Following Combination Treatment with Boceprevir (BOC) Plus PEGINTRON (PegInterferon Alfa-2b) and Ribavirin (P/R)…

Peginterferon Alfa-2a plus Ribavirin vs Peginterferon Alfa-2b plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients J Berenguer*1, J González2,…